Flecainide use before and after the Cardiac Arrhythmia Suppression Trial: A systematic review
Heart Rhythm · 2026-08 · 23 (8) · e1383-e1384
DOI: 10.1016/j.hrthm.2026.02.010 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Heart Rhythm, 2026-08. Verfasst von Christopher O Y Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, BC Children's Hospital, Vancouver, British Columbia, Canada. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The 1989 Cardiac Arrhythmia Suppression Trial (CAST) remains a defining moment in modern cardiology. It dismantled the hypothesis that arrhythmia suppression was synonymous with improved survival after it demonstrated that ventricular ectopy suppression with class IC anti-arrhythmics, including flecainide, paradoxically increased mortality in patients with prior myocardial infarction (MI).1 Since then, flecainide acetate has evolved from a broad-spectrum suppressor of ventricular ectopy to a targeted therapy for atrial fibrillation (AF) and inherited arrhythmia syndromes in structurally normal hearts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, BC Children's Hospital, Vancouver, British Columbia, Canada.
- BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
- Division of Cardiology, BC Children's Hospital, Vancouver, British Columbia, Canada; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
- Division of Cardiology, BC Children's Hospital, Vancouver, British Columbia, Canada; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada. Electronic address: ssanatani@cw.bc.ca.
Zitieren
APA
Li, C. O. Y., Wong, S., Kardel, M. D., Franciosi, S., Katyal, A., Cheung, M., Wei, S., Braschel, M., Roston, T. M., Vijayashankar, S. S., & Sanatani, S. (2026). Flecainide use before and after the Cardiac Arrhythmia Suppression Trial: A systematic review. Heart Rhythm, 23(8), e1383-e1384. https://doi.org/10.1016/j.hrthm.2026.02.010
Vancouver
Li COY, Wong S, Kardel MD, Franciosi S, Katyal A, Cheung M, et al. Flecainide use before and after the Cardiac Arrhythmia Suppression Trial: A systematic review. Heart Rhythm. 2026;23(8):e1383-e1384. doi:10.1016/j.hrthm.2026.02.010
BibTeX
@article{Li2026,
author = {Li, Christopher O Y and Wong, Samantha and Kardel, Melanie D and Franciosi, Sonia and Katyal, Abhay and Cheung, Matthew and Wei, Sabrina and Braschel, Melissa and Roston, Thomas M and Vijayashankar, Sakethram Saravu and Sanatani, Shubhayan},
title = {Flecainide use before and after the Cardiac Arrhythmia Suppression Trial: A systematic review},
journal = {Heart Rhythm},
year = {2026},
volume = {23},
number = {8},
pages = {e1383--e1384},
doi = {10.1016/j.hrthm.2026.02.010}
}
EUVIMED